Cargando…
The beneficial role of Hepcidin peptide inhibitor in improved the symptoms of COVID-19 in diabetics: anti-inflammatory and potential therapeutic effects
Coronavirus Disease 2019 (COVID-19) is a recent public health issue worldwide. Also, diabetes is a frequent condition with high mortality. There is a strong relationship between COVID-19 and diabetes. This article analyses the intricate relationship between COVID-19 and hepcidin. Hepcidin increases...
Autores principales: | Zeinivand, Motahareh, jamali-Raeufy, Nida, Zavvari, Fahime |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257556/ https://www.ncbi.nlm.nih.gov/pubmed/35812243 http://dx.doi.org/10.1007/s40200-022-01053-9 |
Ejemplares similares
-
Hepatocyte Growth Factor Attenuates the Severity of Status Epilepticus in Kainic Acid-induced Model of Temporal Lobe Epilepsy by Targeting Apoptosis and Astrogliosis
por: Haghani, Sobhan, et al.
Publicado: (2021) -
Ibuprofen Protection Against Restrained Chronic Stress-induced Depression in Male Rats
por: Nozari, Masoumeh, et al.
Publicado: (2020) -
Deferoxamine has the Potential to Improve the COVID-19-Related Inflammatory Response in Diabetic Patients
por: Zeinivand, Motahareh, et al.
Publicado: (2023) -
Dalteparin as a Novel Therapeutic Agent to Prevent Diabetic Encephalopathy by Targeting Oxidative Stress and Inflammation
por: Zeinivand, Motahareh, et al.
Publicado: (2020) -
Hepcidin Therapeutics
por: Katsarou, Angeliki, et al.
Publicado: (2018)